BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu F, Ma J, Wang K, Li Z, Jiang Q, Chen H, Li W, Xia J. High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma. J Cancer 2019;10:6252-60. [PMID: 31772658 DOI: 10.7150/jca.35443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Zhang X, Mao T, Xu H, Cui J, Lin H, Wang L. CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway. J Cancer 2021;12:2797-806. [PMID: 33854580 DOI: 10.7150/jca.54482] [Reference Citation Analysis]
2 Lu MY, Wu JR, Liang RB, Wang YP, Zhu YC, Ma ZT, Zhang H, Zan J, Tan W. Upregulation of miR-219a-5p Decreases Cerebral Ischemia/Reperfusion Injury In Vitro by Targeting Pde4d. J Stroke Cerebrovasc Dis 2020;29:104801. [PMID: 32249206 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ragusa F, Panera N, Cardarelli S, Scarsella M, Bianchi M, Biagioni S, Giorgi M, Alisi A, Massimi M. Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:2182. [PMID: 34062786 DOI: 10.3390/cancers13092182] [Reference Citation Analysis]